BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 32364413)

  • 1. High-throughput screening in multicellular spheroids for target discovery in the tumor microenvironment.
    Calpe B; Kovacs WJ
    Expert Opin Drug Discov; 2020 Aug; 15(8):955-967. PubMed ID: 32364413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNAi High-Throughput Screening of Single- and Multi-Cell-Type Tumor Spheroids: A Comprehensive Analysis in Two and Three Dimensions.
    Fu J; Fernandez D; Ferrer M; Titus SA; Buehler E; Lal-Nag MA
    SLAS Discov; 2017 Jun; 22(5):525-536. PubMed ID: 28277887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The multicellular tumor spheroid model for high-throughput cancer drug discovery.
    LaBarbera DV; Reid BG; Yoo BH
    Expert Opin Drug Discov; 2012 Sep; 7(9):819-30. PubMed ID: 22788761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-time viability and apoptosis kinetic detection method of 3D multicellular tumor spheroids using the Celigo Image Cytometer.
    Kessel S; Cribbes S; Bonasu S; Rice W; Qiu J; Chan LL
    Cytometry A; 2017 Sep; 91(9):883-892. PubMed ID: 28618188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The production of 3D tumor spheroids for cancer drug discovery.
    Sant S; Johnston PA
    Drug Discov Today Technol; 2017 Mar; 23():27-36. PubMed ID: 28647083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment and Analysis of a 3D Co-Culture Spheroid Model of Pancreatic Adenocarcinoma for Application in Drug Discovery.
    Meier-Hubberten JC; Sanderson MP
    Methods Mol Biol; 2019; 1953():163-179. PubMed ID: 30912022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large-Scale Gene Expression Profiling Platform for Identification of Context-Dependent Drug Responses in Multicellular Tumor Spheroids.
    Senkowski W; Jarvius M; Rubin J; Lengqvist J; Gustafsson MG; Nygren P; Kultima K; Larsson R; Fryknäs M
    Cell Chem Biol; 2016 Nov; 23(11):1428-1438. PubMed ID: 27984028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3D high-content screening for the identification of compounds that target cells in dormant tumor spheroid regions.
    Wenzel C; Riefke B; Gründemann S; Krebs A; Christian S; Prinz F; Osterland M; Golfier S; Räse S; Ansari N; Esner M; Bickle M; Pampaloni F; Mattheyer C; Stelzer EH; Parczyk K; Prechtl S; Steigemann P
    Exp Cell Res; 2014 Apr; 323(1):131-143. PubMed ID: 24480576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Generation of Three-Dimensional Head and Neck Cancer Models for Drug Discovery in 384-Well Ultra-Low Attachment Microplates.
    Close DA; Camarco DP; Shan F; Kochanek SJ; Johnston PA
    Methods Mol Biol; 2018; 1683():355-369. PubMed ID: 29082502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using 3D in vitro cell culture models in anti-cancer drug discovery.
    Langhans SA
    Expert Opin Drug Discov; 2021 Aug; 16(8):841-850. PubMed ID: 33823728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-throughput screening with nanoimprinting 3D culture for efficient drug development by mimicking the tumor environment.
    Yoshii Y; Furukawa T; Waki A; Okuyama H; Inoue M; Itoh M; Zhang MR; Wakizaka H; Sogawa C; Kiyono Y; Yoshii H; Fujibayashi Y; Saga T
    Biomaterials; 2015 May; 51():278-289. PubMed ID: 25771018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Multiparametric Drug-Scoring Method for High-Throughput Screening of 3D Multicellular Tumor Spheroids Using the Celigo Image Cytometer.
    Cribbes S; Kessel S; McMenemy S; Qiu J; Chan LL
    SLAS Discov; 2017 Jun; 22(5):547-557. PubMed ID: 28346096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-Time Apoptosis and Viability High-Throughput Screening of 3D Multicellular Tumor Spheroids Using the Celigo Image Cytometer.
    Kessel S; Cribbes S; Bonasu S; Qiu J; Chan LL
    SLAS Discov; 2018 Feb; 23(2):202-210. PubMed ID: 28915356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticancer drug discovery using multicellular tumor spheroid models.
    Zanoni M; Pignatta S; Arienti C; Bonafè M; Tesei A
    Expert Opin Drug Discov; 2019 Mar; 14(3):289-301. PubMed ID: 30689452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3D cell culture systems modeling tumor growth determinants in cancer target discovery.
    Thoma CR; Zimmermann M; Agarkova I; Kelm JM; Krek W
    Adv Drug Deliv Rev; 2014 Apr; 69-70():29-41. PubMed ID: 24636868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug screening of biopsy-derived spheroids using a self-generated microfluidic concentration gradient.
    Mulholland T; McAllister M; Patek S; Flint D; Underwood M; Sim A; Edwards J; Zagnoni M
    Sci Rep; 2018 Oct; 8(1):14672. PubMed ID: 30279484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of Multicellular Tumor Spheroids with Microwell-Based Agarose Scaffolds for Drug Testing.
    Gong X; Lin C; Cheng J; Su J; Zhao H; Liu T; Wen X; Zhao P
    PLoS One; 2015; 10(6):e0130348. PubMed ID: 26090664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of 3-D cultures for high-throughput screening: the multicellular spheroid model.
    Kunz-Schughart LA; Freyer JP; Hofstaedter F; Ebner R
    J Biomol Screen; 2004 Jun; 9(4):273-85. PubMed ID: 15191644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applicability of tumor spheroids for
    Hamilton G; Rath B
    Expert Opin Drug Metab Toxicol; 2019 Jan; 15(1):15-23. PubMed ID: 30484335
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of a magnetic 3D spheroid platform with potential application for high-throughput drug screening.
    Guo WM; Loh XJ; Tan EY; Loo JS; Ho VH
    Mol Pharm; 2014 Jul; 11(7):2182-9. PubMed ID: 24842574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.